Drug intelligence / Profile preview

Astion Skin Cure

Development stage: Preclinical
Lead developer: Astion Pharma
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

**Astion Skin Cure** is a cortisone-free topical cream from Astion Pharma for itching, irritation, dryness, redness, and scaling associated with eczema or dermatitis affecting the body. Its patented active ingredient, **Dermadexin**, is described as a biolipid-niacin complex that forms a thin protective film over irritated skin, helping retain moisture, alleviate itching, and support restoration of the skin barrier. The product is an over-the-counter skin-care treatment rather than a conventional systemic pharmaceutical.

Brand names: Astion Pharma Skin CureAstion Skin Cure
Other names: Skin Cure

Beyond the preview

Go deeper on Astion Skin Cure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astion Skin Cure.

Explore the full profile